Our previous report indicated that PROCR concomitantly activates multiple pathways including ERK, PI3K–Akt–mTOR, and RhoA–Rock–P38 signaling in breast cancer cells (Wang et al., 2018). Here, MTOR is linked to breast carcinoma.